Jaclyn Garlich, OD, FAAO, joins Program Chair Kelly K. Nichols, OD, MPH, PhD, FAAO, in a case study discussion about a patient with dry eye disease whose symptoms were severely affecting his quality of life. Drs. Garlich and Nichols converse about symptom presentation and a combination of treatments that may offer the best resolution of symptoms as well as patient satisfaction.
This activity is supported by unrestricted educational grants from Alcon, Sun Pharma, and Viatris.
Upon completion of this activity, the participant should be able to:
Provided by Evolve Medical Education 
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Sponsored by: 
Evolve Medical Education LLC is a COPE-accredited administrator.
This activity, COPE Activity Number 129606, is accredited by COPE for continuing education for optometrists. This course is approved for 0.25 hour of CE.
Course #: 94539-TD
Activity #: 129606
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Kelly K. Nichols, OD, MPH, PhD, FAAO
University of Alabama at Birmingham
Professor and Dean of the
School of Optometry
Birmingham, AL
Jaclyn Garlich, OD, FAAO
Envision Optometry
Boston, MA
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Kelly K. Nichols, OD, MPH, PhD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: AbbVie, Alcon, Alderya, Azura Ophthalmics, Bausch + Lomb, Bruder Healthcare, Cavalry, Dompé, HanAll Biopharma, Harrow, Novaliq, Novartis, Oyster Point Pharma, Sydnexis, Tarsus Pharmaceuticals, TearSolutions, Théa Pharma, Topcon, and Trukera Medical. Grant/Research Support: Aramis, Kowa, ScienceBased Health, Sylentis, and TearScience. Stock/Shareholder: Cavalry.
Jaclyn Garlich, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: AbbVie/Allergan, Alcon, Aldeyra, Bausch + Lomb, Bruder Healthcare, Dompé, Lumenis, Novartis, Orasis Pharmaceuticals, Oyster Point Pharma, Tarsus Pharmaceuticals, and Théa Pharma. Speaker's Bureau: Bausch + Lomb and Tarsus Pharmaceuticals.
The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Alcon, Sun Pharma, or Viatris.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Eye on the Target: Navigating Ocular Challenges With ADC Cancer Therapies
1.00 credit
Kathleen N. Moore, MD, MS, FASCO
Aaron Samuel Gold, OD, FAAO
Carlo J. Pelino, OD, FAAO
Aaron Samuel Gold, OD, FAAO
Timothy G. Murray, MD, MBA, FASRS
Paul Petrakos, DO, MS
Justin Schweitzer, OD, FAAO
I. Paul Singh, MD
Sarah H. Van Tassel, MD
Paul Petrakos, DO, MS
I. Paul Singh, MD
